3940-27-0

Basic information

• Product Name: ETHYL 2-AMINO-3-HYDROXYPROPANOATE HYDROCHLORIDE
• Synonyms: H-DL-Serine ethyl ester hydrochloride;NSC 29417;H-DL-Serine ethyl ester HCl;H-DL-Ser-OEt·HCl;ETHYL 2-AMINO-3-HYDROXYPROPANOATE HYDROCHLORIDE;DL-SERINE ETHYL ESTER HYDROCHLORIDE;ethyl2-amino-3-hydroxypropanoateHCl;(D,L)-ethyl 2-amino-3-hydroxypropanoate hydrochloride
• CAS NO: 3940-27-0
• Molecular Formula: C₅H₁₁NO₃*ClH
• Molecular Weight: 169.61
• Mol File: 3940-27-0.mol

Chemical Properties

• Melting Point: 98-100°C
• Boiling Point: 247.9°Cat760mmHg
• Flash Point: 103.7°C
• Appearance: /
• Density: 1.146g/cm³
• Vapor Pressure: 0.00407mmHg at 25°C
• Refractive Index: 1.463
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: ETHYL 2-AMINO-3-HYDROXYPROPANOATE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 2-AMINO-3-HYDROXYPROPANOATE HYDROCHLORIDE(3940-27-0)
• EPA Substance Registry System: ETHYL 2-AMINO-3-HYDROXYPROPANOATE HYDROCHLORIDE(3940-27-0)

Safety Data

• Statements: 22-36/37/38
• Safety Statements: 22-26-36/37/39
• Hazardous Substances Data: 3940-27-0(Hazardous Substances Data)

Usage

Uses

H-DL-Serine ethyl ester HCl

InChI:InChI=1/C5H11NO3/c1-2-9-5(8)4(6)3-7/h4,7H,2-3,6H2,1H3/t4-/m1/s1

Upstream product

• 64-17-5 ethanol 
• 302-84-1 serin 
• 3850-40-6 N-Boc-DL-serine 
• 56-45-1 L-serin 

Downstream Products

• 111033-46-6 N-(N^α-benzyloxycarbonyl-N^ω-nitro-L-arginyl)-Ξ-serine ethyl ester 
• 23161-27-5 benzyloxycarbonylserine ethyl ester 
• 141567-53-5 4-hydroxymethyl-2-methyloxazole 
• 1220122-29-1 3-hydroxymethyl-1-phenylbenzofuro[3,2-d]imidazo[1,2-a]pyrimidine-2,5-(1H,3H)-dione 
• 70018-62-1 2-(2-Chloro-6-nitro-benzylamino)-3-hydroxy-propionic acid ethyl ester 
• 7521-84-8 2-[bis-(2-chloro-ethyl)-amino]-2-oxo-2λ⁵-[1,3,2]oxazaphospholidine-4-carboxylic acid ethyl ester 
• 54798-74-2 4-carboethoxy-2-phenyl-2-oxazoline 

Relevant articles and documents

NovelN-transfer reagent for converting α-amino acid derivatives to α-diazo compounds

A novel universalN-transfer reagent for direct and effective transformation of α-amino ketones, acetamides, and esters to the corresponding α-diazo products under mild basic conditions has been developed. This one-step synthetic approach not only allows for generation of α-substituted-α-diazo carbonyl compounds from α-amino acid derivatives but also permits preparation of α-diazo dipeptides fromN-terminal dipeptides (32 examples, up to 91%).

N-transfer reagent and method for preparing the same and its application

Provided are a novel N-transfer reagent and a method for preparing the same and its application. The N-transfer reagent is represented by the following Formula (I): The various novel N-transfer reagents of the present invention can be quickly prepared by employing different nitrobenzene precursors. The N-transfer reagents can directly convert a variety of amino compounds into diazo compounds under mild conditions. Particularly, the N-transfer reagents can facilitate the synthesis of the diazo compounds. The application of synthesizing diazo compounds of the present invention can greatly decrease the difficulty in operation, increase the safety during experiments, reduce the cost of production and the environmental pollution, and enhance the industrial value of diazo compounds.

Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors

Ergosterol as the core component of fungal cell membrane plays a key role in maintaining cell morphology and permeability. The squalenee epoxidase (SE) and 14-demethylase (CYP51) are the important rate-limiting enzymes for ergosterol synthesis. In the study, these active fragments, which is derived from the structural groups of the common antifungal agents, were docked into the active sites of dual targets (SE, CYP51), respectively. Some of active fragments with the matching MCSS_Score values were selected and connected to construct three different series of novel arylalkene-amide derivatives as dual-target (SE, CYP51) antifungal inhibitors. Subsequently, these compounds were further synthesized, and their bioactivity was evaluated. Most of compounds showed a certain degree of antifungal activity in vitro. It was worth noting that the target compounds 17a and 25a with excellent antifungal activity (0.125–4 μg/mL) can inhibit the fluconazole-resistant Candida Strain 17#, CaR, 632, and 901 in the range of MIC values (4–8 μg/mL). Furthermore, their molecular mechanism, structural stability and low toxicity were further confirmed. The molecular docking and ADMET properties were predicted to guide the subsequent optimization of target compounds.

Synthesizing method using serine to prepare Ramipril key intermediate

The invention relates to a synthesizing method using serine to prepare a Ramipril key intermediate. The Ramipril key intermediate is 2-azabicyclo[3.3.0] octane-3-carboxylic acid hydrochloride or benzyl ester hydrochloride. The synthesizing method includes: using the serine as the initial raw material, and sequentially performing esterification, acyl chloride acylation, deacidification, Michael addition, hydrolysis and hydrogenation reduction to obtain the Ramipril key intermediate. The synthesizing method has the advantages that the key intermediate is synthesized by a five-step method, and the synthesizing method is cheap in raw material, environmentally friendly, simple in preparation process, simple to operate, mild in reaction condition, short in reaction cycle, convenient in post-treatment, low in equipment requirement, capable of avoiding heavy metal pollution and the use of expensive catalysts, few in three wastes, high in product yield and purity and suitable for industrial production.

LTA4 hydrolase inhibitors

The invention concerns LTA4hydrolase inhibiting compositions of formula (1) as set forth below. It also concerns their therapeutic, in particular anti-inflammatory, applications.